Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vergès

Showing results (1-10 of 497) with videos related to

Pageof 50
Sort By:
Journees Annuelles De Diabetologie De L'Hotel-Dieu|September 22, 2001
[Is it necessary to systematically treat diabetics with statins?]B Vergès
Acta Urologica Belgica|July 1, 1981
[4 cases of angiomyolipoma. Surgical strategy]J Vergès
Expert Opinion on Pharmacotherapy|February 18, 2011
Combination lipid therapy in type 2 diabetes mellitusBruno Vergès
Fundamental & Clinical Pharmacology|August 5, 2009
Lipid modification in type 2 diabetes: the role of LDL and HDLBruno Vergès
Transplantation|March 7, 2017
mTOR and Cardiovascular Diseases: Diabetes MellitusBruno Vergès
Annales D'Endocrinologie|December 29, 1998
[Cardiovascular risk and dyslipidemias]B Vergès
Current Opinion in Lipidology|November 11, 2006
Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELDBruno Vergès
La Revue De Medecine Interne|July 1, 1991
[Anomalies of lipid metabolism in diabetes mellitus]B Vergès
Current Opinion in Lipidology|November 9, 2005
Role for fibrate therapy in diabetes: evidence before FIELDBruno Vergès
Annales D'Endocrinologie|March 25, 2023
Diabetes Induced by Immune Checkpoint Inhibitors (ICIs)Bruno Vergès
Pageof 50

Showing results (1-10 of 497) with videos related to

Sort By:
Pageof 50
Journees Annuelles De Diabetologie De L'Hotel-Dieu|September 22, 2001
[Is it necessary to systematically treat diabetics with statins?]B Vergès
Acta Urologica Belgica|July 1, 1981
[4 cases of angiomyolipoma. Surgical strategy]J Vergès
Expert Opinion on Pharmacotherapy|February 18, 2011
Combination lipid therapy in type 2 diabetes mellitusBruno Vergès
Fundamental & Clinical Pharmacology|August 5, 2009
Lipid modification in type 2 diabetes: the role of LDL and HDLBruno Vergès
Transplantation|March 7, 2017
mTOR and Cardiovascular Diseases: Diabetes MellitusBruno Vergès
Annales D'Endocrinologie|December 29, 1998
[Cardiovascular risk and dyslipidemias]B Vergès
Current Opinion in Lipidology|November 11, 2006
Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELDBruno Vergès
La Revue De Medecine Interne|July 1, 1991
[Anomalies of lipid metabolism in diabetes mellitus]B Vergès
Current Opinion in Lipidology|November 9, 2005
Role for fibrate therapy in diabetes: evidence before FIELDBruno Vergès
Annales D'Endocrinologie|March 25, 2023
Diabetes Induced by Immune Checkpoint Inhibitors (ICIs)Bruno Vergès
Pageof 50